Abstract
Caspase-3, -6 and -7 cleave many proteins at specific sites to induce apoptosis. Their recognition of the P5 position in substrates has been investigated by kinetics, modeling and crystallography. Caspase-3 and -6 recognize P5 in pentapeptides as shown by enzyme activity data and interactions observed in the crystal structure of caspase-3/LDESD and in a model for caspase-6. In caspase-3 the P5 main-chain was anchored by interactions with Ser209 in loop-3 and the P5 Leu side-chain interacted with Phe250 and Phe252 in loop-4 consistent with 50% increased hydrolysis of LDEVD relative to DEVD. Caspase-6 formed similar interactions and showed a preference for polar P5 in QDEVD likely due to interactions with polar Lys265 and hydrophobic Phe263 in loop-4. Caspase-7 exhibited no preference for P5 residue in agreement with the absence of P5 interactions in the caspase-7/LDESD crystal structure. Initiator caspase-8, with Pro in the P5-anchoring position and no loop-4, had only 20% activity on tested pentapeptides relative to DEVD. Therefore, caspases-3 and -6 bind P5 using critical loop-3 anchoring Ser/Thr and loop-4 side-chain interactions, while caspase-7 and -8 lack P5-binding residues.
Similar content being viewed by others
Abbreviations
- Ac:
-
Acetyl
- CHO:
-
Aldehyde
- pNA:
-
p-Nitroanilide
- RMS:
-
Root mean square
References
Tacconi S, Perri R, Balestrieri E et al (2004) Increased caspase activation in peripheral blood mononuclear cells of patients with Alzheimer’s disease. Exp Neurol 190(1):254–262. doi:10.1016/j.expneurol.2004.07.009
Hartmann A, Troadec JD, Hunot S et al (2001) Caspase-8 is an effector in apoptotic death of dopaminergic neurons in Parkinson’s disease, but pathway inhibition results in neuronal necrosis. J Neurosci 21(7):2247–2255
Hermel E, Gafni J, Propp SS et al (2004) Specific caspase interactions and amplification are involved in selective neuronal vulnerability in Huntington’s disease. Cell Death Differ 11(4):424–438. doi:10.1038/sj.cdd.4401358
LeBlanc AC (2005) The role of apoptotic pathways in Alzheimer’s disease neurodegeneration and cell death. Curr Alzheimer Res 2(4):389–402. doi:10.2174/156720505774330573
Zidar N, Jera J, Maja J, Dusan S (2007) Caspases in myocardial infarction. Adv Clin Chem 44:1–33. doi:10.1016/S0065-2423(07)44001-X
Takemura G, Fujiwara H (2006) Morphological aspects of apoptosis in heart diseases. J Cell Mol Med 10(1):56–75. doi:10.1111/j.1582-4934.2006.tb00291.x
Kim HS, Lee JW, Soung YH et al (2003) Inactivating mutations of caspase-8 gene in colorectal carcinomas. Gastroenterology 125(3):708–715. doi:10.1016/S0016-5085(03)01059-X
Soung YH, Lee JW, Kim SY et al (2005) CASPASE-8 gene is inactivated by somatic mutations in gastric carcinomas. Cancer Res 65(3):815–821
Volkmann X, Cornberg M, Wedemeyer H et al (2006) Caspase activation is required for antiviral treatment response in chronic hepatitis C virus infection. Hepatology 43(6):1311–1316. doi:10.1002/hep.21186
Lakhani SA, Masud A, Kuida K et al (2006) Caspases 3 and 7: key mediators of mitochondrial events of apoptosis. Science 311(5762):847–851. doi:10.1126/science.1115035
Fischer U, Schulze-Osthoff K (2005) Apoptosis-based therapies and drug targets. Cell Death Differ 12(Suppl 1):942–961. doi:10.1038/sj.cdd.4401556
Baskin-Bey ES, Washburn K, Feng S et al (2007) Clinical trial of the pan-caspase inhibitor, IDN-6556, in human liver preservation injury. Am J Transplant 7(1):218–225. doi:10.1111/j.1600-6143.2006.01595.x
Lavrik IN, Golks A, Krammer PH (2005) Caspases: pharmacological manipulation of cell death. J Clin Invest 115(10):2665–2672. doi:10.1172/JCI26252
Fuentes-Prior P, Salvesen GS (2004) The protein structures that shape caspase activity, specificity, activation and inhibition. Biochem J 384(Pt 2):201–232. doi:10.1042/BJ20041142
Fischer U, Janicke RU, Schulze-Osthoff K (2003) Many cuts to ruin: a comprehensive update of caspase substrates. Cell Death Differ 10(1):76–100. doi:10.1038/sj.cdd.4401160
Wei Y, Fox T, Chambers SP et al (2000) The structures of caspases-1, -3, -7 and -8 reveal the basis for substrate and inhibitor selectivity. Chem Biol 7(6):423–432. doi:10.1016/S1074-5521(00)00123-X
Schweizer A, Briand C, Grutter MG (2003) Crystal structure of caspase-2, apical initiator of the intrinsic apoptotic pathway. J Biol Chem 278(43):42441–42447. doi:10.1074/jbc.M304895200
Shiozaki EN, Chai J, Rigotti DJ et al (2003) Mechanism of XIAP-mediated inhibition of caspase-9. Mol Cell 11(2):519–527. doi:10.1016/S1097-2765(03)00054-6
Thornberry NA, Rano TA, Peterson EP et al (1997) A combinatorial approach defines specificities of members of the caspase family and granzyme B. Functional relationships established for key mediators of apoptosis. J Biol Chem 272(29):17907–17911. doi:10.1074/jbc.272.29.17907
Fang B, Boross PI, Tozser J, Weber IT (2006) Structural and kinetic analysis of caspase-3 reveals role for s5 binding site in substrate recognition. J Mol Biol 360(3):654–666. doi:10.1016/j.jmb.2006.05.041
Timmer JC, Salvesen GS (2007) Caspase substrates. Cell Death Differ 14(1):66–72. doi:10.1038/sj.cdd.4402059
Garcia-Calvo M, Peterson EP, Rasper DM et al (1999) Purification and catalytic properties of human caspase family members. Cell Death Differ 6(4):362–369. doi:10.1038/sj.cdd.4400497
Agniswamy J, Fang B, Weber IT (2007) Plasticity of S2–S4 specificity pockets of executioner caspase-7 revealed by structural and kinetic analysis. FEBS J 274(18):4752–4765. doi:10.1111/j.1742-4658.2007.05994.x
Otwinowski Z, Minor W (1997) Processing of X-ray diffraction data collected in oscillation mode. Methods Enzymol 276:307–326. doi:10.1016/S0076-6879(97)76066-X
McCoy AJ, Grosse-Kunstleve RW, Storoni LC, Read RJ (2005) Likelihood-enhanced fast translation functions. Acta Crystallogr D Biol Crystallogr 61(4):458–464
Potterton E, Briggs P, Turkenburg M, Dodson E (2003) A graphical user interface to the CCP4 program suite. Acta Crystallogr D Biol Crystallogr 59(7):1131–1137
Sheldrick GM, Schneider TR (1997) SHELXL: High-resolution refinement. Methods Enzymol 277:319–343
Jones TA, Zou JY, Cowan SW, Kjeldgaard (1991) Improved methods for building protein models in electron density maps and the location of errors in these models. Acta Crystallogr A 47(2):110–119
Emsley P, Cowtan K (2004) Coot: model-building tools for molecular graphics. Acta Crystallogr D Biol Crystallogr 60(12–1):2126–2132
Lovell SC, Davis IW, Arendall WBIII et al (2003) Structure validation by Calpha geometry: phi, psi and Cbeta deviation. Proteins 50(3):437–450
Thompson JD, Higgins DG, Gibson TJ (1994) CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Nucleic Acids Res 22(22):4673–4680
Merritt EA, Murphy ME (1994) Raster3D Version 2.0. A program for photorealistic molecular graphics. Acta Crystallogr D Biol Crystallogr 50(6):869–873
Kullback S (1959) Information theory and statistics. Wiley, New York
Altschul SF, Madden TL, Schaffer AA et al (1997) Gapped BLAST and PSI-BLAST: a new generation of protein database search programs. Nucleic Acids Res 25(17):3389–3402
Harrison RW (1993) Stiffness and Energy Conservation in Molecular Dynamics: an Improved Integrator. J Comp Chem 14:1112–1122
Harrison RW, Chatterjee D, Weber IT (1995) Analysis of six protein structures predicted by comparative modeling techniques. Proteins 23(4):463–471
Bagossi P, Tozser J, Weber IT, Harrison RW (1999) Modification of parameters of the charge equilibrium scheme to achieve better correlation with experimental dipole moments. J Mol Model 5:143–152
Harrison RW (1999) A Self-Assembling Neural Network for Modeling Polymers. J Math Chem 26:125–137
Wilson KP, Black JA, Thomson JA et al (1994) Structure and mechanism of interleukin-1 beta converting enzyme. Nature 370(6487):270–275
Talanian RV, Quinlan C, Trautz S et al (1997) Substrate specificities of caspase family proteases. J Biol Chem 272(15):9677–9682
Onteniente B (2004) Natural and synthetic inhibitors of caspases: targets for novel drugs. Curr Drug Targets CNS Neurol Disord 3(4):333–340
Acknowledgements
G.F. and B·F. were supported in part by the Georgia State University Research Program Enhancement award. B·F. was supported by the Georgia State University Molecular Basis of Disease Fellowship. I.T.W. and R.W·H. are Georgia Cancer Coalition Distinguished Cancer Scholars. This research was supported in part by the Georgia Research Alliance, the Georgia Cancer Coalition and the National Institutes of Health award GM065762. We thank the staff at the SER-CAT beamline at the Advanced Photon Source, Argonne National Laboratory, for assistance during X-ray data collection. Use of the Advanced Photon Source was supported by the U. S. Department of Energy, Office of Science, Office of Basic Energy Sciences, under Contract No. DE-AC02-06CH11357.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Fu, G., Chumanevich, A.A., Agniswamy, J. et al. Structural basis for executioner caspase recognition of P5 position in substrates. Apoptosis 13, 1291–1302 (2008). https://doi.org/10.1007/s10495-008-0259-9
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10495-008-0259-9